Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates | Zendy

V. Ramos-Martín | Zendy; Adam Johnson | Zendy; Joanne Livermore | Zendy; Laura McEntee | Zendy; Joanne Goodwin | Zendy; Sarah Whalley | Zendy; Fernando Docobo-Pérez | Zendy; Tim Felton | Zendy; Wei Zhao | Zendy; Evelyne JacqzAigrain | Zendy; Mike Sharland | Zendy; M. Turner | Zendy; William Hope | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

Author(s) -

V. Ramos-Martín,

Adam Johnson,

Joanne Livermore,

Laura McEntee,

Joanne Goodwin,

Sarah Whalley,

Fernando Docobo-Pérez,

Tim Felton,

Wei Zhao,

Evelyne JacqzAigrain,

Mike Sharland,

M. Turner,

William Hope

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv451

Subject(s) - pharmacodynamics , pharmacokinetics , cmax , medicine , vancomycin , pharmacology , population , cons , minimum inhibitory concentration , antibiotics , biology , microbiology and biotechnology , staphylococcus aureus , bacteria , computer science , genetics , programming language , environmental health

CoNS are the most common cause of neonatal late-onset sepsis. Information on the vancomycin pharmacokinetics/pharmacodynamics against CoNS is limited. The aim of this study was to characterize vancomycin pharmacokinetic/pharmacodynamic relationships for CoNS and investigate neonatal optimal dosage regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research